دانلودمقاله باموضوع غشایی-گلومرولوپاتی-بعد از-اتولوگ-خونساز-_2021_کلیه-اینترن
در قالب pdf و در 3 اسلاید،قابل ویرایش، شامل:
موضوع به انگلیسی:Membranous Glomerulopathy After
Autologous Hematopoietic Stem Cell
Transplant in a Patient With Multiple
Myeloma
بخشی از متن:Autologous hematopoietic stem cell transplant
(HSCT) is a standard treatment for multiple
myeloma (MM).1 It is well known that kidney
dysfunction related to MM, either acute or chronic,
may be multifactorial, with factors including cast
nephropathy and other paraprotein-associated renal
diseases, nephrotoxicity owing to chemotherapy,
immunosuppressive agents, and direct infiltration of
neoplastic cells, among others. Furthermore, HSCT
per se adds additional risks of developing kidney
dysfunction with issues related to nephrotoxicity
from medications, thrombotic microangiopathy,
graft-versus-host disease (GVHD), and increased risk
of infectious diseases.2 There were 2 different
studies that aimed to characterize renal biopsy
findings in patients who underwent HSCT, either
autologous or allogenic, for various indications,
including MM, which have described membranous
glomerulopathy (MGN), thrombotic microangiopathy,
focal and segmental glomerulosclerosis,
minimal change disease, acute tubular injury,
tubulointerstitial nephritis, and another less common
diagnosis
